Maxcyte, Inc. Sample Contracts

●] Shares MAXCYTE, INC. Common Stock UNDERWRITING AGREEMENT
Underwriting Agreement • July 26th, 2021 • Maxcyte, Inc. • Services-commercial physical & biological research • New York
AutoNDA by SimpleDocs
SEVERANCE AGREEMENT
Severance Agreement • January 26th, 2024 • Maxcyte, Inc. • Services-commercial physical & biological research • Maryland

THIS SEVERANCE AGREEMENT is made as of March 10, 2023 (the “Effective Date”), by and between MaxCyte, Inc., a Delaware corporation (the "Company"), and Cenk Sumen (the "Executive").

INDEMNIFICATION AGREEMENT
Indemnification Agreement • July 26th, 2021 • Maxcyte, Inc. • Services-commercial physical & biological research • Delaware

This Indemnification Agreement (this “Agreement”) dated as of July ___, 2021, is made by and between MaxCyte, Inc., a Delaware corporation (the “Company”), and _________________ (“Indemnitee”).

DEED OF LEASE
Deed of Lease • March 15th, 2023 • Maxcyte, Inc. • Services-commercial physical & biological research

This Lease (the “Lease”) is made this ____ day of ___________, 2021 (the “Effective Date”), between KEY WEST MD OWNER LLC, a Delaware limited liability company (“Landlord”), and MAXCYTE, INC., a Delaware corporation (“Tenant”).

SEVERANCE AGREEMENT
Severance Agreement • March 15th, 2023 • Maxcyte, Inc. • Services-commercial physical & biological research • Maryland

THIS SEVERANCE AGREEMENT is made as of March 8, 2017 (the "Effective Date"), by and between MaxCyte, Inc., a Delaware corporation (the "Company"), and Ronald E. Holtz (the "Executive").

MAXCYTE, INC. LONG-TERM INCENTIVE PLAN NON-STATUTORY STOCK OPTION AGREEMENT FOR US PERSONS
Non-Statutory Stock Option Agreement • June 25th, 2021 • Maxcyte, Inc. • Services-commercial physical & biological research
Gaithersburg, MD 20878
Maxcyte, Inc. • August 10th, 2022 • Services-commercial physical & biological research • Illinois
EIGHTH AMENDMENT TO LEASE AGREEMENT
Lease Agreement • June 25th, 2021 • Maxcyte, Inc. • Services-commercial physical & biological research

THIS EIGHTH AMENDMENT TO LEASE AGREEMENT (“this Eighth Amendment”) is made as of September 27, 2019 (“Eighth Amendment Effective Date”), by and between ARE-20/22/1300 FIRSTFIELD QUINCE ORCHARD, LLC, a Delaware limited liability company, having an address at 385 E Colorado Boulevard, Suite 299, Pasadena, California 91101 (“Landlord”), and MAXCYTE, INC., a Delaware corporation, having an address at 22 Firstfield Road, Suite 110, Gaithersburg, Maryland 20878 (“Tenant”).

AMENDMENT TO DEED OF LEASE
Deed of Lease • March 15th, 2023 • Maxcyte, Inc. • Services-commercial physical & biological research

THIS AMENDMENT TO DEED OF LEASE (this “Amendment”) is made this ____ day of ____________________, 2021 (the “Effective Date”), by and between key west md owner llc, a Delaware limited liability company (“Landlord”), and MAXCYTE, INC., a Delaware corporation (“Tenant”).

FIRST AMENDMENT TO SUBLEASE
First Amendment • June 25th, 2021 • Maxcyte, Inc. • Services-commercial physical & biological research

This First Amendment to Sublease (“First Amendment”) is entered into as of the 9th day of September, 2019, by and between NOVAVAX, INC., a Delaware corporation (“Sublandlord”), and MAXCYTE, INC., a Delaware corporation (“Subtenant”).

MAXCYTE, INC. LONG-TERM INCENTIVE PLAN NON-STATUTORY STOCK OPTION AGREEMENT FOR US PERSONS
Stock Option Agreement • June 25th, 2021 • Maxcyte, Inc. • Services-commercial physical & biological research
FIRST AMENDMENT TO SUBLEASE
First Amendment • June 25th, 2021 • Maxcyte, Inc. • Services-commercial physical & biological research

This First Amendment to Sublease (“First Amendment”) is entered into as of the 9th day of September, 2019, by and between NOVAVAX, INC., a Delaware corporation (“Sublandlord”), and MAXCYTE, INC., a Delaware corporation (“Subtenant”).

SUBLEASE
Sublease • June 25th, 2021 • Maxcyte, Inc. • Services-commercial physical & biological research

This Sublease (“Sublease”) is made as of the 9th day of September, 2019 (the “Effective Date”), by and between Novavax, Inc., a Delaware corporation (“Sublandlord”), and MaxCyte, Inc., a Delaware corporation (“Subtenant”).

AMENDMENT TO DEED OF LEASE
Deed of Lease • March 22nd, 2022 • Maxcyte, Inc. • Services-commercial physical & biological research

THIS AMENDMENT TO DEED OF LEASE (this “Amendment”) is made this ____ day of ____________________, 2021 (the “Effective Date”), by and between key west md owner llc, a Delaware limited liability company (“Landlord”), and MAXCYTE, INC., a Delaware corporation (“Tenant”).

CONSULTING AGREEMENT
Consulting Agreement • August 10th, 2022 • Maxcyte, Inc. • Services-commercial physical & biological research • Illinois

This Consulting Agreement (the “Agreement”) by and between MaxCyte, Inc. (“Client”) and Amanda Murphy, an individual (“Consultant”) is effective as of April 15, 2022 (the “Effective Date”).

Contract
Transition Agreement • March 12th, 2024 • Maxcyte, Inc. • Services-commercial physical & biological research • Maryland
Contract
Maxcyte, Inc. • March 12th, 2024 • Services-commercial physical & biological research
Time is Money Join Law Insider Premium to draft better contracts faster.